If you have held till now, I encourage you to hold for a few more weeks. I expect to see a few updates in the coming weeks.
1. FDA 501k approval for MEBsleep
Substantive review start = 24/08/2020
45day timeline = 08/10/2020
I suspect the company is providing answers to queries from the reviewer and an ANN that the application has been accepted for Interactive review (30day review) or that application is approved may be released soon-ish. I understand the Interactive review could be a series of phone calls and correspondences to provide some clarifications.
2. CE Mark application for MEBsleep
30/08/2020 - Technical file for MEBsleep submitted (Step 5 below)
3. MEB001 FDA Breathrough Device Designation (60day process)
Submitted application = 02/10/2020
Approval = 01/12/2020
4. Other Anns regarding Ilumen and software app development.
At MCAP of about $16m, it's not impossible to trading at $64m by Christmas based on peer review. Am I missing something here?
DYOR
- Forums
- ASX - By Stock
- TRI
- Ann: FDA Strategy and Regulatory Update
Ann: FDA Strategy and Regulatory Update, page-331
-
- There are more pages in this discussion • 362 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TRI (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.226M |
Open | High | Low | Value | Volume |
1.9¢ | 1.9¢ | 1.7¢ | $16.41K | 912.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1157999 | 1.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.8¢ | 58353 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1157999 | 0.017 |
8 | 1369687 | 0.016 |
6 | 687223 | 0.015 |
3 | 186000 | 0.014 |
2 | 230000 | 0.013 |
Price($) | Vol. | No. |
---|---|---|
0.018 | 58353 | 2 |
0.019 | 632972 | 2 |
0.020 | 100000 | 1 |
0.021 | 437698 | 2 |
0.022 | 221111 | 1 |
Last trade - 12.53pm 13/11/2024 (20 minute delay) ? |
Featured News
TRI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online